Financials
- Market Capitalization 42.8 M
- Employee 20
- Founded 1971
- CEO N/A
- Website www.verupharma.com
- Headquarter Wisconsin, United States
- FIGI BBG000G12J78
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-5.23
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4297 | CNTX Context Therapeutics Inc. - Common Stock | 0.48 USD | -4.00% | -7.69% | -21.31% | -46.07% | 44.10 M USD | ||
| 4300 | MCRB Seres Therapeutics, Inc. - Common Stock | 4.54 USD | -0.44% | -0.66% | -8.84% | -44.84% | 45.13 M USD | ||
| 4310 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.85 USD | -5.61% | -5.61% | -75.17% | -80.81% | 41.96 M USD | ||
| 4315 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.44 USD | -4.59% | -2.28% | +41.23% | +592.47% | 41.93 M USD |